Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Klaus-Peter Jünemann
Long Term Progression Free Survival Achieved by Maintenance “Second–Line” Polychemotherapy With Gemcitabine/Paclitaxel in Metastatic Urothelial Cancer of the Renal Pelvis—A Case Report
Journal of Cancer Therapy
Related publications
Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma
Modern Chemotherapy
Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma
Anticancer Research
Medicine
Cancer Research
Oncology
Front-Line Treatment With Gemcitabine, Paclitaxel, and Doxorubicin for Patients With Unresectable or Metastatic Urothelial Cancer and Poor Renal Function: Final Results From a Phase II Study
Urology
Urology
Extended Progression-Free Survival of Renal Cell Carcinoma With Axitinib: Case Report
Journal of Urology and Renal Diseases
Long-Term Survival in a Case of Renal Cell Carcinoma With Brain Metastases: A Case Report
Clinical Medicine Insights: Case Reports
Medicine
Long-Term Survival in a Patient With Metastatic Squamous Cell Lung Carcinoma: A Case Report
Molecular and Clinical Oncology
Cancer Research
Oncology
Long-Term Progression-Free Survival of Third-Line Apatinib in Lung Squamous Cell Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
Genetic Polymorphisms Associated With a Prolonged Progression-Free Survival in Patients With Metastatic Renal Cell Cancer Treated With Sunitinib
Clinical Cancer Research
Cancer Research
Oncology
Long‑term Survival in a Recipient of Kidney Transplant Without Maintenance Immunosuppression: A Case Report
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
